Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Portal Hypertension
When would you choose to measure a patient's spleen stiffness?
What are you looking for that would impact your management of a patient?
Related Questions
What is your endoscopic approach to the management of refractory GAVE in persistently anemic patients?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
How do you utilize urine sodium and potassium levels and ratios in diuretic optimization in patients with ascites?
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
How do you utilize liver assisive devices in the management algorithm of patients with acute liver failure?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
How do you prefer to manage IgG-4 related hepato-biliary disease, especially if there are similarities in imaging findings to other immune mediated liver diseases?
What kind of follow up or monitoring do you recommend for patients with at risk alpha-1-anti-trypsin phenotypes?
Do you find there is any benefit to giving N-acetyl-cysteine in non-acetaminophen related acute liver failure?
What is your preferred approach to a patient with incidentally found low ceruloplasmin?